Cancer patients, their families had their hopes raised when the results of the first human trial of Dichloroacetate DCA were released, researchers say that this result provides a new approach for treating cancer. Tumors shrank during treatment and their conditions were stable by the time the trial ended. A second test is ongoing at the Cross Cancer Institute for 18 patients with other types of cancers

The University of Alberta Discovers that Dichloroacetate (DCA) as a possible Cancer Treatment DCA is an odorless, colorless, inexpensive, relatively non-toxic, small molecule. And researchers at the University of Alberta believe it may soon be used as an effective treatment for many forms of cancer.

DCA is an odorless, colorless, inexpensive, relatively non-toxic, small molecule. And researchers at the University of Alberta believe it may soon be used as an effective treatment for many forms of cancer.